Abbott RealTime CT/NG
Device
Abbott Laboratories
Total Payments
$655,418
Transactions
9
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $655,418 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $655,418 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Rectal and Oropharyngeal swabs to diagnose gonococcal and chlamydial infection in men and women | Abbott Laboratories | $655,418 | 0 |
Top Doctors Receiving Payments for Abbott RealTime CT/NG
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Francisco, CA | $655,418 | 9 |
Ad
Manufacturing Companies
- Abbott Laboratories $655,418
Product Information
- Type Device
- Total Payments $655,418
- Total Doctors 0
- Transactions 9
About Abbott RealTime CT/NG
Abbott RealTime CT/NG is a device associated with $655,418 in payments to 0 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $655,418 was paid across 9 transactions to 0 doctors.
The most common payment nature for Abbott RealTime CT/NG is "Unspecified" ($655,418, 100.0% of total).
Abbott RealTime CT/NG is associated with 1 research study, including "Rectal and Oropharyngeal swabs to diagnose gonococcal and chlamydial infection in men and women" ($655,418).